Pancreatic Cancer Research

ResearcherIcahn School of Medicine at Mount SinaiNo recent work listed

Xufen Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7794-7890; OpenAlex author ID A5045578425. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer. Co-author DOI 10.1021/acs.jmedchem.3c01521↗
  2. Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism. Co-author DOI 10.1016/j.celrep.2019.09.056↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian Jun Jin · 2 shared papers, 2019–2023 · strength 0.22
  2. Nithya Sivaram · 1 shared paper, 2019 · strength 0.07
  3. Claudia Tonelli · 1 shared paper, 2019 · strength 0.07
  4. Alex J. Bott · 1 shared paper, 2019 · strength 0.07
  5. Daniel J. Murphy · 1 shared paper, 2019 · strength 0.07
  6. Jennifer P. Morton · 1 shared paper, 2019 · strength 0.07
  7. Richard Z Lin · 1 shared paper, 2019 · strength 0.07
  8. Wei‐Xing Zong · 1 shared paper, 2019 · strength 0.07
  9. Nathiya Muthalagu · 1 shared paper, 2019 · strength 0.07
  10. David Arthur Tuveson · 1 shared paper, 2019 · strength 0.07
  11. Howard C. Crawford · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.